Protective role of B cells in inflammation also suggests a limitation of the application of BTK inhibitors for inflammatory diseases; however, if BTK inhibitors are used only during the acute phase of stroke, effects on B cells may be negligible. The gene discussed is BTK; the disease is stroke disorder.